EUVIMEDEUVIMED entdecken
Vergleichsstudie

Lower levels of senescence in human lung mesenchymal stromal cells compared with lung fibroblasts: implications for tissue regeneration in COPD

Marissa Wisman iD, Dennis M L W Kruk, Wierd Kooistra, Irene H Heijink iD, Roy R Woldhuis iD

American Journal of Physiology-Lung Cellular and Molecular Physiology · 2025

DOI: 10.1152/ajplung.00366.2024 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift American Journal of Physiology-Lung Cellular and Molecular Physiology, 2025. Verfasst von Marissa Wisman und 4 weiteren Autor:innen. Beteiligte Einrichtung: University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Cellular Senescence, Fibroblasts, Mesenchymal Stem Cells. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Longfonds (Lung Foundation Netherlands).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We demonstrate that LMSCs are less sensitive to senescence induction by oxidative stress and replication than LFs, which was accompanied by an increased ability to expand. This makes LMSCs more suitable for cell-based therapies in COPD. As senescence affected growth factors involved in alveolar repair, specifically FGF10 expression in both LMSCs and LFs, we additionally suggest that the development of anti-senescence strategies may promote endogenous tissue repair in COPD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveCellular SenescenceFibroblastsMesenchymal Stem CellsLungRegenerationHumansMaleMiddle AgedFemaleAgedCell ProliferationCells, Culturedbeta-GalactosidaseInterleukin-6Hepatocyte Growth Factor

Stichwörter der Autor:innen

COPDlung mesenchymal stromal cellssenescencetissue regeneration

Substanzen

beta-GalactosidaseInterleukin-6Hepatocyte Growth Factor

Autor:innen und Institutionen

  • University of Groningen, University Medical Centre Groningen, Department of Pathology and Medical Biology, Groningen, The Netherlands.
  • University of Groningen, University Medical Centre Groningen, Department of Pulmonary Diseases, Groningen, The Netherlands.
  • University of Groningen, University Medical Centre Groningen, Groningen Research Institute for Asthma and COPD (GRIAC), Groningen, The Netherlands.

ORCID-Profile: Marissa Wisman, Irene H Heijink, Roy R Woldhuis

Förderung

  • Longfonds (Lung Foundation Netherlands)

Zitieren

APA

Wisman, M., Kruk, D. M. L. W., Kooistra, W., Heijink, I. H., & Woldhuis, R. R. (2025). Lower levels of senescence in human lung mesenchymal stromal cells compared with lung fibroblasts: implications for tissue regeneration in COPD. American Journal of Physiology-Lung Cellular and Molecular Physiology. https://doi.org/10.1152/ajplung.00366.2024

Vancouver

Wisman M, Kruk DMLW, Kooistra W, Heijink IH, Woldhuis RR. Lower levels of senescence in human lung mesenchymal stromal cells compared with lung fibroblasts: implications for tissue regeneration in COPD. American Journal of Physiology-Lung Cellular and Molecular Physiology. 2025. doi:10.1152/ajplung.00366.2024

BibTeX
@article{Wisman2025,
  author = {Wisman, Marissa and Kruk, Dennis M L W and Kooistra, Wierd and Heijink, Irene H and Woldhuis, Roy R},
  title = {Lower levels of senescence in human lung mesenchymal stromal cells compared with lung fibroblasts: implications for tissue regeneration in COPD},
  journal = {American Journal of Physiology-Lung Cellular and Molecular Physiology},
  year = {2025},
  doi = {10.1152/ajplung.00366.2024}
}
Kostenlos starten →